Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A brachydactyly characterized by short and broad terminal phalanges of the thumbs and big toes that has material basis in mutation in the HOXD13 gene on chromosome 2q31.1.
Features include: Broad distal phalanx of the hallux, Broad distal phalanx of the thumb, and Type D brachydactyly.
HOXD13 encodes homeobox D13 (343 aa). Sequence-specific transcription factor that binds gene promoters and activates their transcription. Highest expression in Colon Sigmoid (34.0 TPM) and Vagina (31.9 TPM).
Brachydactyly type D is associated with mutations in the HOXD13 gene on chromosome 2.
HOXD13 is classified as a druggable target (Clinically Actionable and Transcription Factor categories) with score 26.1.
Genetic testing for HOXD13 is available. Testing is considered confirmatory for diagnosis.
No clinical trials have been registered for brachydactyly type D.
2 publications have been identified in PubMed for brachydactyly type D. Research spans Case Report / Case Series (50%) and Basic Science / Preclinical (50%).
Mokhtari A (2026). [PMID: 40842263](https://pubmed.ncbi.nlm.nih.gov/40842263/). *Clin Genet*. [Basic Science / Preclinical]
Yang X (2025). [PMID: 40119734](https://pubmed.ncbi.nlm.nih.gov/40119734/). *Am J Med Genet A*. [Case Report / Case Series]
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 11:10 AM UTC
Online Mendelian Inheritance in Man
European rare disease database